Literature DB >> 18724054

Dominant non-coding repeat expansions in human disease.

K A Dick1, J M Margolis, J W Day, L P W Ranum.   

Abstract

The general model that dominant diseases are caused by mutations that result in a gain or change in function of the corresponding protein was challenged by the discovery that the myotonic dystrophy type 1 mutation is a CTG expansion located in the 3' untranslated portion of a kinase gene. The subsequent discovery that a similar transcribed but untranslated CCTG expansion in an intron causes the same multisystemic features in myotonic dystrophy type 2 (DM2), along with other developments in the DM1 field, demonstrate a mechanism in which these expansion mutations cause disease through a gain of function mechanism triggered by the accumulation of transcripts containing CUG or CCUG repeat expansions. A similar RNA gain of function mechanism has also been implicated in fragile X tremor ataxia syndrome (FXTAS) and may play a role in pathogenesis of other non-coding repeat expansion diseases, including spinocerebellar ataxia type 8 (SCA8), SCA10, SCA12 and Huntington disease-like 2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18724054     DOI: 10.1159/000092501

Source DB:  PubMed          Journal:  Genome Dyn        ISSN: 1660-9263


  7 in total

1.  Initiation of translation of the FMR1 mRNA Occurs predominantly through 5'-end-dependent ribosomal scanning.

Authors:  Anna L Ludwig; John W B Hershey; Paul J Hagerman
Journal:  J Mol Biol       Date:  2011-01-12       Impact factor: 5.469

Review 2.  Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells.

Authors:  Shira Yanovsky-Dagan; Hagar Mor-Shaked; Rachel Eiges
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

3.  Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Authors:  Guangbin Xia; Yuanzheng Gao; Shouguang Jin; S H Subramony; Naohiro Terada; Laura P W Ranum; Maurice S Swanson; Tetsuo Ashizawa
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

Review 4.  Regulatory RNAs in brain function and disorders.

Authors:  Anna Iacoangeli; Riccardo Bianchi; Henri Tiedge
Journal:  Brain Res       Date:  2010-03-20       Impact factor: 3.252

5.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

Review 6.  A brief history of triplet repeat diseases.

Authors:  Helen Budworth; Cynthia T McMurray
Journal:  Methods Mol Biol       Date:  2013

Review 7.  The spinocerebellar ataxias.

Authors:  Henry L Paulson
Journal:  J Neuroophthalmol       Date:  2009-09       Impact factor: 3.042

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.